Personalized Sarcoma Care
ASO Keyword Dashboard
Tracking 84 keywords for Personalized Sarcoma Care in Google Play
Personalized Sarcoma Care tracks 84 keywords (no keywords rank yet; 84 need traction). Key metrics: opportunity 71.2, difficulty 43.4.
PERSARC is for treatment information only and does NOT provide medical advice
Tracked keywords
84
0 ranked • 84 not ranking yet
Top 10 coverage
—
Best rank — • Latest leader —
Avg opportunity
71.2
Top keyword: survival
Avg difficulty
43.4
Lower scores indicate easier wins
Opportunity leaders
- 65.3
survival
Opportunity: 74.0 • Difficulty: 47.4 • Rank —
Competitors: 1,689
- 63.6
patients
Opportunity: 74.0 • Difficulty: 39.0 • Rank —
Competitors: 198
- 64.8
patient
Opportunity: 74.0 • Difficulty: 39.4 • Rank —
Competitors: 201
- 65.7
grade
Opportunity: 74.0 • Difficulty: 49.2 • Rank —
Competitors: 608
- 62.8
soft
Opportunity: 74.0 • Difficulty: 40.1 • Rank —
Competitors: 429
Unranked opportunities
survival
Opportunity: 74.0 • Difficulty: 47.4 • Competitors: 1,689
patients
Opportunity: 74.0 • Difficulty: 39.0 • Competitors: 198
patient
Opportunity: 74.0 • Difficulty: 39.4 • Competitors: 201
grade
Opportunity: 74.0 • Difficulty: 49.2 • Competitors: 608
soft
Opportunity: 74.0 • Difficulty: 40.1 • Competitors: 429
High competition keywords
like
Total apps: 286,956 • Major competitors: 22,420
Latest rank: — • Difficulty: 60.7
mobile
Total apps: 280,903 • Major competitors: 11,070
Latest rank: — • Difficulty: 55.7
information
Total apps: 265,070 • Major competitors: 8,170
Latest rank: — • Difficulty: 54.8
designed
Total apps: 263,588 • Major competitors: 8,518
Latest rank: — • Difficulty: 53.7
using
Total apps: 223,871 • Major competitors: 12,270
Latest rank: — • Difficulty: 57.0
All tracked keywords
Includes opportunity, difficulty, rankings and competitor benchmarks
| Major Competitors | |||||||
|---|---|---|---|---|---|---|---|
| survival | 74 | 100 | 47 | 65 12,461 competing apps Median installs: 21,937 Avg rating: 2.8 | — | — | 1,689 major competitor apps |
| health | 69 | 100 | 49 | 77 68,730 competing apps Median installs: 762 Avg rating: 2.1 | — | — | 1,953 major competitor apps |
| support | 67 | 100 | 55 | 83 165,484 competing apps Median installs: 1,599 Avg rating: 2.6 | — | — | 7,918 major competitor apps |
| medical | 71 | 100 | 44 | 72 33,401 competing apps Median installs: 1,239 Avg rating: 2.1 | — | — | 888 major competitor apps |
| information | 65 | 100 | 55 | 86 265,070 competing apps Median installs: 1,190 Avg rating: 2.2 | — | — | 8,170 major competitor apps |
| used | 68 | 100 | 55 | 81 116,981 competing apps Median installs: 3,110 Avg rating: 2.4 | — | — | 5,188 major competitor apps |
| designed | 65 | 100 | 54 | 86 263,588 competing apps Median installs: 790 Avg rating: 2.2 | — | — | 8,518 major competitor apps |
| treated | 72 | 100 | 32 | 52 1,760 competing apps Median installs: 1,251 Avg rating: 2.3 | — | — | 41 major competitor apps |
| using | 66 | 100 | 57 | 85 223,871 competing apps Median installs: 2,829 Avg rating: 2.4 | — | — | 12,270 major competitor apps |
| mobile | 65 | 100 | 56 | 87 280,903 competing apps Median installs: 1,387 Avg rating: 2.4 | — | — | 11,070 major competitor apps |
| provide | 67 | 100 | 52 | 82 137,697 competing apps Median installs: 1,594 Avg rating: 2.2 | — | — | 5,010 major competitor apps |
| including | 67 | 100 | 56 | 82 130,729 competing apps Median installs: 2,498 Avg rating: 2.6 | — | — | 7,695 major competitor apps |
| patients | 74 | 100 | 39 | 64 9,750 competing apps Median installs: 721 Avg rating: 2.0 | — | — | 198 major competitor apps |
| grow | 71 | 100 | 47 | 73 36,032 competing apps Median installs: 1,186 Avg rating: 2.5 | — | — | 2,013 major competitor apps |
| related | 70 | 100 | 48 | 76 56,850 competing apps Median installs: 1,781 Avg rating: 2.2 | — | — | 1,937 major competitor apps |
| provides | 67 | 100 | 54 | 83 166,932 competing apps Median installs: 1,398 Avg rating: 2.3 | — | — | 5,615 major competitor apps |
| patient | 74 | 100 | 39 | 65 11,589 competing apps Median installs: 595 Avg rating: 2.0 | — | — | 201 major competitor apps |
| tool | 68 | 100 | 50 | 80 100,163 competing apps Median installs: 1,322 Avg rating: 2.4 | — | — | 4,067 major competitor apps |
| together | 70 | 100 | 49 | 74 43,303 competing apps Median installs: 1,970 Avg rating: 2.5 | — | — | 2,437 major competitor apps |
| type | 70 | 100 | 52 | 75 48,957 competing apps Median installs: 4,030 Avg rating: 2.5 | — | — | 2,846 major competitor apps |
| like | 65 | 100 | 61 | 87 286,956 competing apps Median installs: 4,612 Avg rating: 2.6 | — | — | 22,420 major competitor apps |
| work | 68 | 100 | 55 | 81 120,600 competing apps Median installs: 1,885 Avg rating: 2.4 | — | — | 5,259 major competitor apps |
| grade | 74 | 100 | 49 | 66 13,244 competing apps Median installs: 3,306 Avg rating: 2.3 | — | — | 608 major competitor apps |
| specifically | 72 | 100 | 43 | 71 27,288 competing apps Median installs: 865 Avg rating: 2.2 | — | — | 607 major competitor apps |
| soft | 74 | 100 | 40 | 63 8,776 competing apps Median installs: 2,157 Avg rating: 2.5 | — | — | 429 major competitor apps |
App Description
PERSARC is for treatment information only and does NOT provide medical advice
The mobile PERSARC application is a prognostic (forward looking) tool specifically designed to support shared decision making for patients with a primary high-grade soft tissue sarcoma in their limb, (to be) treated with surgical resection (and radiotherapy). The information in this app is relevant for patients with grade III sarcoma, and not for sarcoma subtypes other than those mentioned in the app or patients that receive any form of chemotherapy before or shortly after surgery. Using patient- and tumor-related characteristics, the app provides an estimate of the oncological outcome in terms of overall survival or incidence of local recurrence.
This app is for general health information only and is not meant to base clinical decisions on (the clinical usefulness has not been tested). It is to be used as an informative tool that improves the predictive capability of a physician. Patients and caregivers using this app should discuss the results with the patient’s physician.
